The natural history of secondary progressive multiple sclerosis

Journal of Neurology, Neurosurgery, and Psychiatry
Marcus KochUBC MS Clinic Neurologists

Abstract

The onset of secondary progression is a pivotal event in the course of relapsing-remitting (RR) multiple sclerosis (MS). Patients with secondary progressive MS (SPMS) experience continuous worsening of symptoms independent of the occurrence of relapses. Possible risk factors associated with the onset of SPMS remain under investigated in natural history studies of MS disease course. We used Kaplan-Meier survival analyses and Cox regression models to investigate the influence of gender, onset age and onset symptoms on time to and age at SPMS in British Columbia (BC) MS patients with a RR disease onset who were not exposed to immunomodulatory drugs. Of 5778 patients in the BCMS database with definite MS, 5207 (90%) had an RR onset. Median time to SPMS was 21.4 years (95% CI 20.6 to 22.2), reached at a median age of 53.7 years (95% CI 53.1 to 54.3). Male gender and motor onset symptoms were associated with a shorter time to and a younger age at SPMS. A younger age at disease onset was associated with a longer time to SPMS but also with a younger age at secondary progression. Other onset symptoms were not associated with time to, or age at, SPMS. We identified three factors influencing the onset of SPMS in untreated patients with RR...Continue Reading

Citations

Nov 4, 2011·Lancet·Jeremy Chataway, David H Miller
Aug 30, 2012·JAAPA : Official Journal of the American Academy of Physician Assistants·Victoria BrowningMona Sedrak
Dec 12, 2012·ISRN Neurology·Claudia Cristina Ferreira VasconcelosRegina Maria Papais Alvarenga
Mar 13, 2012·Psychosomatic Medicine·Carsten SpitzerChristoph Heesen
Feb 13, 2013·Cardiovascular Psychiatry and Neurology·Alan M Palmer
Mar 19, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jorge CorrealeMauricio F Farez
Feb 25, 2014·Archives of Physical Medicine and Rehabilitation·James F Sumowski, Victoria M Leavitt
Jun 10, 2014·Current Eye Research·John J ChenRandy H Kardon
Jun 15, 2015·Journal of Clinical Epidemiology·Michael LawtonYoav Ben-Shlomo
Nov 28, 2015·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Pierre DuquetteRobyn Schecter
Jan 5, 2016·Journal of Neurology·Riley BoveD Rintell
Jun 15, 2012·Journal of Magnetic Resonance Imaging : JMRI·René M VigevenoFrederik Barkhof
Nov 21, 2013·British Journal of Clinical Pharmacology·Alan M Palmer
Oct 9, 2015·The Journal of Spinal Cord Medicine·Yael NechemiaGabi Zeilig
Sep 17, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Ludwig KapposBernard M J Uitdehaag
Oct 9, 2013·Journal of Neurology·Riley BoveMaria Houtchens
Apr 9, 2011·Journal of Neuroimmunology·Judith M Greer, Pamela A McCombe
Apr 23, 2015·Brain : a Journal of Neurology·Mar TintoreXavier Montalban
Jan 24, 2012·Lancet Neurology·David H MillerOlga Ciccarelli
May 12, 2016·CNS Drugs·Domenico PlantoneJeremy Chataway
Sep 20, 2016·Multiple Sclerosis and Related Disorders·Gavin GiovannoniTimothy Vollmer
Jul 28, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Ana M NovoFreire Gonçalves
Sep 19, 2016·Neurology and Therapy·Jasna JancicJanko Samardzic
Dec 3, 2016·Expert Review of Molecular Diagnostics·Matteo GastaldiDiego Franciotta
Mar 15, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Antonio ScalfariGeorge Cornell Ebers
Mar 6, 2012·Multiple Sclerosis : Clinical and Laboratory Research·James F SumowskiJohn Deluca
Jan 26, 2017·Journal of Comparative Effectiveness Research·Aseel Bin SawadFatema Turkistani
Dec 14, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Ali ManouchehriniaJan Hillert
Mar 31, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Helen Tremlett, Yinshan Zhao
Apr 27, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Angela Vidal-JordanaXavier Montalban
Oct 21, 2016·Arquivos de neuro-psiquiatria·Juliana Calvet Kallenbach AurençãoRegina Maria Papais Alvarenga
Sep 13, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Menno M SchoonheimJeroen J G Geurts
May 13, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Anne WellekBjörn Tackenberg
Mar 28, 2012·Nature Reviews. Neurology·Rhonda R Voskuhl, Stefan M Gold
Jan 9, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Rhonda R VoskuhlYuichiro Itoh
Jun 19, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Ali ManouchehriniaJan Hillert
Feb 21, 2018·Journal of Health Psychology·Larissa GerhardRachel M Roberts
Oct 27, 2018·Seminars in Immunopathology·Stefan M GoldManuel A Friese
Mar 22, 2019·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Emily DonaldsonAnthony Feinstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.